🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
OVI
$OVID
🔒 US EquitiesOvid Therapeutics Inc
AVG HISTORICAL GAP
+0.99%
MAX GAP RECORD
+19.90%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $OVID
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$OVID
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 18, 2026 Earnings Release 2026-08-18 (AFTER CLOSE) |
+2.11%
|
| May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN) |
-0.36%
|
| Mar 18, 2026 Earnings Release 2026-03-18 (BEFORE OPEN) |
+19.90%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
-9.63%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (BEFORE OPEN) |
+2.74%
|
| May 13, 2025 Earnings Release 2025-05-13 (BEFORE OPEN) |
+2.65%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (BEFORE OPEN) |
+4.08%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.7%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (4)
📖 Intelligence Summary
Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗